BODY VISION MEDICAL

Company profile

About BODY VISION MEDICAL

Body Vision Medical is redefining the standard of care in lung cancer diagnostics and therapies through advanced AI-driven imaging technology. The company's flagship product, the LungVision® system, uses proprietary AI Tomo® technology to transform any standard 2D C-arm into an advanced 3D imaging system with navigation capabilities. This enables real-time, high-precision navigation for biopsy of pulmonary lesions and delivery of localized therapies. The LungVision system addresses a critical challenge in bronchoscopy: CT-to-Body divergence, which is the difference between a lesion's preoperative CT location and its actual location during the procedure. This divergence typically limits diagnostic tissue sample acquisition to 70% or less. Body Vision's technology corrects for this divergence with visual tool-in-lesion confirmation, helping clinicians achieve diagnostic yields approaching 95%. The hardware-light design offers an affordable, low-cost solution with a small, mobile footprint that integrates seamlessly with 2D and 3D C-arms, navigation platforms, bronchoscopes (including robotic systems like Auris Monarch and Ion by Intuitive), and biopsy tools. The system provides 3D imaging quality that rivals cone-beam CT while minimizing both radiation dose (approximately 1/5 to 1/6 the radiation of traditional 3D C-arms) and cost. Body Vision Medical empowers clinicians with enhanced accuracy and confidence, bridging the gap between early detection and improved patient outcomes to make cutting-edge lung cancer interventions more accessible globally.

Company description · BODY VISION MEDICAL official website